• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 17 of 100
After testing new drug compounds that appear to mimic the physical benefits of exercise in rodents, scientists say a pill may someday be able to do the same in humans.
Life
An exercise pill may soon offer the same benefits as a workout, scientists say
By Lindsey LeakeMarch 18, 2024
A man with glasses and a white lab coat stands in front of a glass wall in a medical research facility.
Newsletters
How AI turbocharged the development of a new drug and what it might mean for health care
By Diane BradyMarch 14, 2024
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
Health
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
By Tom Murphy, Matthew Perrone and The Associated PressMarch 8, 2024
“Even though health insurance costs are the second-largest line item after payroll, CEOs don’t really understand it or know anything about it,” billionaire entrepreneur and Shark Tank investor Mark Cuban tells Fortune’s Lindsey Leake.
Health
Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big
By Lindsey LeakeMarch 8, 2024
Photo of Bill Anderson
Health
Bayer CEO compares the state of troubled pharma group to the time he fractured his leg skateboarding: ‘We’re badly broken in 4 places’
By Ryan HoggMarch 6, 2024
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.
Retail
Novo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By Niclas Rolander and BloombergMarch 5, 2024
The Mark Cuban Cost Plus Drug Company will begin manufacturing its own medications in Dallas this week, cofounder and CEO Dr. Alex Oshmyansky announced Monday, March 4, 2024.
Health
Mark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week
By Lindsey LeakeMarch 4, 2024
First over-the-counter birth control pill in U.S. begins shipping to stores
Health
First over-the-counter birth control pill in U.S. begins shipping to stores
By Matthew Perrone and The Associated PressMarch 4, 2024
Stock traders from various companies work in five circular and one semi-circular trading floor at the Frankfurt Stock Exchange.
Finance
Meet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy
By Ryan HoggMarch 3, 2024
BOXES OF WEGOVY DRUGS
Lifestyle
Novo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results
By Prarthana PrakashFebruary 27, 2024
People sit and enjoy drinks in the sunshine at Nyhavn, a waterfront, canal and entertainment district in Copenhagen, Denmark
Newsletters
Denmark, home to Ozempic-maker Novo Nordisk, is now Europe’s third-most prosperous economy
By Peter Vanham and Nicholas GordonFebruary 27, 2024
Sanofi CEO: AI promises a great era of drug discovery that could fundamentally change medicine–but only if we allow it to deliver
Commentary
Sanofi CEO: AI promises a great era of drug discovery that could fundamentally change medicine–but only if we allow it to deliver
By Paul HudsonFebruary 19, 2024
Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers
Health
Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers
By Arthur Allen and KFF Health NewsFebruary 16, 2024
Jill Feldman, 54, poses for a photo at her home in Deerfield, Ill., on Jan. 19. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by blocking a signal that tells cancer cells to grow.
Health
As cancer treatment advances, advocates push back against ‘maximum tolerated dose,’ citing patient suffering
By Carla K. Johnson and The Associated PressFebruary 6, 2024
Patients given a monthly injection of Amgen’s drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according to a small, early-stage study published Monday in the journal Nature Metabolism.
Health
Experimental once-a-month weight loss injectable shows lasting results in early study
By Madison Muller and BloombergFebruary 5, 2024
1...
  • 15
  • 16
  • 17
  • 18
  • 19
...100
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.